INS and type 2 diabetes mellitus: The GLP-1 acts by promoting insulin release and inhibiting glucagon secretion after food ingestion; it delays stomach emptying and inhibits appetite [47]; these mechanisms were shown to be impaired in patients with T2DM who have less differentiated enteroendocrine cells and, as a consequence, impaired GLP-1 response to food ingestion [48].